Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Decoding Cannabis: what the first placebo-controlled cannabis migraine trial means for patients in 2026
The first randomised, placebo-controlled trial of vaporised cannabis for migraine attacks has finally been published. Researchers at UC San Diego compared THC, CBD, a balanced combination, and placebo across 247 treated migraines. The balanced ratio came out clearly ahead, with sustained benefit at 24 and 48 hours and no serious adverse events. We unpack what the trial proves, where it falls short, and how the results sit alongside Releaf's UK patient survey data on medical cannabis for migraine.
Quick reads
Articles
Say hello to the new Releaf Starter Kits: PAX or Storz & Bickel
Available right now, Releaf’s new Starter Kits give patients the choice between the compact PAX Mini and the medical-grade Storz & Bickel Venty. Each kit includes carefully selected accessories and CBD products designed to support precise, effective administration of prescribed medical cannabis. Available exclusively through the Releaf Shop for anyone with a Releaf login.
Inside the clinic: UK medical cannabis specialist doctors discuss CBG
CBG is attracting attention as one of the most versatile minor cannabinoids in medical cannabis. This blog brings together reflections from Releaf’s UK medical cannabis specialists on what early research and clinical experience suggest about its potential in patient care.
NHS access to medical cannabis could add over £13 billion in the UK economy over 10 years
A new report has found that rolling out access to medical cannabis on the NHS could unlock an estimated £13.3 billion for the UK economy over the next decades, in addition to helping thousands of people get back to work. The report comes as medical cannabis patient numbers saw a significant increase between 2023 and 2024, with almost all patients accessing the medications through private clinics.
New best practice guidelines for prescribing UK medical cannabis released
The Medical Cannabis Clinicians Society (MCCS) has released new prescribing guidelines for cannabis-based medicines following the CQC’s report on sector standards. Here’s what the update means for clinicians, patients, and the future of regulated medical cannabis care in the UK.